The Cambridge Clinical Vision Laboratory (CCVL) is an innovative cross-cutting facility established on the Cambridge Biomedical Campus with support from the NIHR Cambridge Biomedical Research Centre and the Cambridge Eye Trust. The vision of the CCVL is to enhance our capacity to conduct advanced therapeutic studies for ocular and neurological diseases in Cambridge, with a particular focus on gene therapy and cell-based therapies.
The CCVL has been developed to facilitate clinical research that helps to further our understanding of ocular and neurological disorders, including the effects they have on the function and structure of the eyes and brain; the impact they have on affected individuals; and how we can modify disease progression with new treatment modalities.
The eyes look – but the brain sees. Almost half of the human brain is dedicated to vision-related activities, including sight and eye movements. Many neurological disorders are associated with vision problems and it is increasingly recognised that even in the absence of problems with sight or eye movements, the effects of some neurological disorders can be detected in the eyes. Although the CCVL is an important element of the mitoCAMB research group, we also support a broad portfolio of research projects on the Cambridge Biomedical Campus.
Read on to find out more about who we are, the tests that we can perform, and the research that is being conducted in the CCVL.